# US 2016/0354494 A1 · Cleavable coating material having microbial functionality

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354494 A1
- Document ID: US20160354494A1
- Status: Published application
- Kind: A1
- Application number: 14/653,418
- Filed: 2013-12-20
- Published: 2016-12-08
- Earliest claimed: 2012-12-21
- Applicants: Original G B.V.
- Inventors: Jurjen GAZENDAM
- Web page: https://patentgrep.com/patent/US20160354494A1

## CPC

- A61K 49/0054: {Macromolecular compounds, i.e. oligomers, polymers, dendrimers}
- A61B 5/0071: {by measuring fluorescence emission}
- A61B 5/0077: {Devices for viewing the surface of the body, e.g. camera, magnifying lens}
- A61K 47/65: Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
- A61K 49/0002: {General or multifunctional contrast agents, e.g. chelated agents}
- A61L 27/34: Macromolecular materials
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 29/085: {Macromolecular materials}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 31/10: Macromolecular materials
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- C09D 189/00: Coating compositions based on proteins; Coating compositions based on derivatives thereof
- G01N 33/54353: {with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393)}
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L 2300/406: Antibiotics
- A61L 2300/602: Type of release, e.g. controlled, sustained, slow
- A61L 2300/606: Coatings
- A61L 2420/02: Methods for coating medical devices
- A61L 2420/06: Coatings containing a mixture of two or more compounds
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C09D: COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR (cosmetics A61K; processes for applying liquids or other fluent materials to surfaces, in general, B05D; staining wood B27K5/02; glazes or vitreous enamels C03C; natural resins, French polish, drying-oils, driers, turpentine, per se, C09F; polishing compositions other than French polish, ski waxes C09G; adhesives or use of materials as adhesives C09J; materials for sealing or packing joints or covers C09K3/10; materials for stopping leaks C09K3/12; processes for the electrolytic or electrophoretic production of coatings C25D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Described is a an object comprising a polymer coating, the coating comprising one or more polymers, wherein said polymers comprise a first cleavage site, and a first agent releasable from said coating upon cleavage of said first cleavage site. The first cleavage site is cleaved by a first compound specifically provided by a microbe belonging to a first group consisting of a limited number of microbial strains, species or genera, and not cleaved by any compound provided by any microbe not belonging to said first group, wherein cleavage of the said first cleavage site results in release of the said first agent from the coating, the release of said first agent being indicative for the presence of a microbe belonging to the said first group. Further, methods of detecting a microbial infection and of visualizing the presence of microbes are presented.

## Claims

### Claim 40

Object comprising a polymer coating, the coating comprising:
a) one or more polymers, the polymers comprising a first cleavage site; and
b) a first agent releasable from the coating upon cleavage of the first cleavage site;
wherein the first cleavage site is cleaved by a first compound specifically provided by a microbe belonging to a first group, consisting of a limited number of microbial strains, species or genera, and not cleaved by any compound provided by any microbe not belonging to the first group, wherein the cleavage of the first cleavage site results in the release of the first agent from the coating, the release of the first agent being indicative for the presence of a microbe belonging to the first group.

### Claim 41 (depends on 40)

Object according to claim 40, having at least a primary first function and a second auxiliary function, the second auxiliary function comprising the release of the first agent from the coating, the first primary function being unrelated to the coating or the release of the first agent therefrom, preferably the object being intended to be implanted in a patient's body during invasive surgery.

### Claim 42 (depends on 40)

Object according to claim 40, wherein the polymer coating further comprises
c) one or more polymers, said polymers comprising a second cleavage site; and
d) a second agent releasable from the coating upon cleavage of the second cleavage site;
wherein the second cleavage site is cleaved by a second compound specifically provided by a microbe belonging to a second group, consisting of a limited number of microbial strains, species or genera and not cleaved by any compound provided by any microbe not belonging to the first group, wherein the cleavage of the second cleavage site results in the release of the second agent from the coating, the release of the second agent being indicative for the presence of a microbe belonging to the second group;
wherein the second cleavage site is different from the first cleavage site and is not cleavable by the first compound; and
wherein the limited number of microbial strains, species or genera of the second group are different to those of the first group; and
wherein the second agent is preferably different from the first agent.

### Claim 43 (depends on 40)

Object according to claim 40, wherein the first compound is an enzyme.

### Claim 44 (depends on 40)

Object according to claim 40, wherein the first agent is covalently bound to the first polymer via a first linker, the first linker comprising the first cleavage site, and wherein the second agent is covalently bound to a second polymer via a second linker, the second linker comprising the second cleavage site; and optionally wherein the coating comprises a first additional agent, which is released upon cleavage of the first cleavage site; and optionally wherein the coating comprises a second additional agent, which is released upon cleavage of the second cleavage site.

### Claim 45 (depends on 44)

Object according to claim 44, wherein the first and/or second linker comprises one or more bonds chosen from the group consisting of amide bonds, ester bonds, thioester bonds, carbamate bonds, preferably amide bonds; the linker preferably comprising a peptide and/or wherein the first and/or second cleavage site comprises a specific amino acid motif, preferably chosen from the group consisting of PPTP (SEQ NO: 2), PPSP (SEQ NO: 3), LPATG (SEQ NO: 4), LPETG (SEQ NO: 5), LPDTG (SEQ NO: 6), LPQTG (SEQ NO: 7), NPQTN (SEQ NO: 8), NPKTN (SEQ NO: 9), GGA, GGL, AAR, AAF, GFPRG (SEQ NO:10) and GfPRG (SEQ NO:11).

### Claim 46 (depends on 3, 4, 5, 6)

Object according to any of the preceding claims, wherein the first agent for any one of the preceding claims and/or for any one of the claims 3-6 the second agent and for any one of claims 5-6 optionally the first additional agent and optionally the second additional agent is a therapeutic agent or a diagnostic agent;
preferably the therapeutic agent is chosen from the group consisting of beta-lactam antibiotics, cephalosporin antibiotics, macrolides, cyclic depsipeptides and tetracyclines, preferably cyclic depsipeptides, more preferably vancomycin;
preferably the diagnostic agent being a photon emitting agent, preferably chosen from the group consisting of a fluorescent agent, a bioluminescent agent, a luminescent agent, a chemoluminescent agent or a nuclear agent, preferably being a the fluorescent agent IRDye®800CW.

### Claim 47 (depends on 46)

Object according to claim 46, wherein the first and/or second additional agent is covalently bound to a first and/or second additional polymer via a first and/or second additional linker, the first and/or second additional linker comprising the first and/or cleavage site respectively, preferably wherein the first and/or second additional linker is identical to the first and/or second linker, and preferably wherein the first and/or second additional polymer is identical to the first and/or second polymer.

### Claim 48 (depends on 40)

Object according to claim 40, wherein the first polymer and/or, if present, the first additional polymer and/or, if present, the second polymer and/or, if present, the second additional polymer comprises a hydrogel, preferably a biodegradable polymer, more preferably a polyethylene glycol, even more preferably polyethylene glycol vinyl-sulfone or polyethylene glycol diacrylate, most preferably polyethylene glycol diacrylate.

### Claim 49 (depends on 40)

Object according to claim 40, wherein the object is chosen from the group consisting of medical apparatus, medical injection or infusion needles, medical implants and food contacting surfaces.

### Claim 50 (depends on 40)

Method of sensing photon emission from an object according to claim 40, wherein the first agent comprises a photon emitting agent; the method comprising the step of:
radiating the object with light capable of inducing photon emission from the first agent when released from the coating; and
registering the photon emission, wherein the photon emission is indicative for the presence of a microbial strain, species or genus of the first group.

### Claim 51 (depends on 40)

Method of producing a coated object according to claim 40, the method comprising the steps of:
a) dip coating an object in a solution of a polymer comprising a first cleavage site and a first and optionally a first additional agent, and, if present, a polymer comprising a second cleavage site and a second agent and optionally a second additional agent to obtain a dipped object; and
b) drying the dipped object to produce a coated object.

### Claim 52

A polymer coating, comprising:
a) one or more polymers, the polymers comprising a first cleavage site; and
b) a first agent releasable from the coating upon cleavage of the first cleavage site;
wherein the first cleavage site is cleaved by a first compound specifically provided by a microbe belonging to a first group, consisting of a limited number of microbial strains, species or genera, and not cleaved by any compound provided by any microbe not belonging to the first group, wherein the cleavage of the first cleavage site results in the release of the first agent from the coating, the release of the first agent being indicative for the presence of a microbe belonging to the first group.

### Claim 53 (depends on 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50)

Use of an object according to anyone of claims 40-50 for monitoring and/or treating a microbial infection, in particular a biofilm associated infection.

### Claim 54 (depends on 41, 53)

Use of a polymer coating according to claim 53 for coating an object, in particular an implantable device, in particular an object as defined in claim 41, for monitoring the presence of an infection and/or monitoring the development of an infection and/or treatment thereof, wherein the infection is in particular a biofilm associated infection.
